DXCM Q3 2025 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.2B+21.6% YoY

Gross Profit

$731M60.5% margin

Operating Income

$243M20.1% margin

Net Income

$284M23.5% margin

EPS (Diluted)

$0.70

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$660M

Free Cash Flow

$579M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$7.5B

Total Liabilities

$4.8B

Stockholders' Equity

$2.7B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$994M	+21.6%
Gross Profit	$731M	$594M	+23.2%
Operating Income	$243M	$152M	+59.5%
Net Income	$284M	$135M	+110.8%

Geographic Segments

UNITED STATES

$852M70%

Non-US

$357M30%